People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bernd Brust will shift out of his position as president of Life Technologies' commercial operations and will move into the role of president of Molecular Medicine, the company said in a filing yesterday with the US Securities and Exchange Commission.

Brust will be replaced as president of commercial operations at the beginning of the coming year by Nicolas Barthelemy, who has been leading the firm's Cell Systems division.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.